期刊文献+

精神分裂症患者药物治疗后血糖、血脂和尿酸代谢变化及相关因素分析 被引量:13

下载PDF
导出
摘要 目的:探讨精神分裂症患者经抗精神病药物治疗后空腹血糖(FPG)、血脂和尿酸(UA)代谢的变化及其影响因素。方法:收集我院住院的精神分裂症患者122例,其中男102例,女20例。治疗前测量FPG、甘油三酯(TG)、总胆固醇(TC)、UA浓度。根据以往用药疗效及临床特征选择相应的抗精神病药物治疗。治疗第4周末复查上述指标。结果:122例精神分裂症患者治疗4周后TG、TC增高(P<0.01),治疗后高甘油三酯血症、高胆固醇血症发生率增高(P<0.01)。通过person积差相关因素分析显示影响治疗后血清TG浓度的因素为FPG(r=0.206,P=0.024)、TC(r=0.503,P=0.001)、UA(r=0.362,P=0.001)。影响治疗后血清TC浓度的因素为FPG(r=0.219,P=0.018)、TG(r=0.503,r=0.001)、UA(r=0.339,P=0.001),与年龄、病程、抗精神病药物剂量均无明显相关性。结论:抗精神病药物治疗对精神分裂症患者血脂代谢有明显影响,且血脂水平与FPG、UA水平具有明显相关性。
出处 《温州医学院学报》 CAS 2013年第5期340-342,共3页 Journal of Wenzhou Medical College
  • 相关文献

参考文献11

  • 1Dixon L,Weiden P, Delahanty J, et al. Prevalence andcorrelates of diabetes in national schizophrenia samples[J].Schizophren Buff, 2000,26(4): 903-912.
  • 2Despres JP. Health consequences of visceral obesity [J]. AnnMed, 2001, 33(8): 534-541.
  • 3Melkersson KI,Hulting AL, Brismar KE. Elevated levels ofinsulin leptin and blood lipids in olanzapine-treated patientswith schizophrenia or related psychoses[J]. J Clin Psychiatry,2000,61(10): 742-749.
  • 4Osser DN, Najarian DM, Dufresne RL. Olanzapine increasesweight and serum triglyceride levels[J]. J Clin Psychiatry,1999, 60(11): 767-770.
  • 5Henderson DC, Cagliero E, Gray C,et al. Clozapine, diabe-tes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study [J]. Am J Psychiatry, 2000,157(6):975-981.
  • 6Lieberman JA, Tollefson G, Tohen M, et al. Comparativeefficacy and safety of atyipical and conventional antipsy-chotic drugs in firs episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol[J]. Am J Psy-chiatry, 2003,160(8): 1396-1404.
  • 7Smith H, Kenney-Herdert J, Knowles L. Clozapine-induceddiabetic ketoaeidesis[J]. Aust New Zealand J Psyehiatry,1999,33(1): 120-122.
  • 8陈俊雄,吴树跃,林榕.齐拉西酮与奥氮平对老年精神分裂症患者糖脂代谢的影响及疗效[J].广东医学,2012,33(7):1006-1008. 被引量:55
  • 9徐勇.不同剂量氯丙嗪治疗精神分裂症的疗效及对血糖血脂的影响[J].四川精神卫生,2012,25(4):197-199. 被引量:1
  • 10Newcomer JW. Metabolic syndrome and mental illness [J].Am J Manag Care, 2007, 13(Suppl 7): 170-177.

二级参考文献12

  • 1陈远光,谢光荣.精神分裂症患者口服氯丙嗪的血药浓度与临床效应的关系[J].中华神经精神科杂志,1994,27(3):153-155. 被引量:7
  • 2DIXON L, WEIDEN P, DELAHANTY J, et al. Prevalence and correlates of diabetes in national schizophrenia samp les [ J ]. Schizophren Buff, 2000, 26(4) : 903 -912.
  • 3DESPRES J P. Health consequences of visceral obesity [ J ]. Ann Med, 2001, 33(8): 534-541.
  • 4SIMPSON G M, GLICK I D, WEIDEN P J, et al. Randomized. controlled, double - blind muhicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder [ J ]. Am J Psychiatry, 2004, 161 (10) : 1837 - 1847.
  • 5NASRALLAH H A. Atypical antipsychotic - induced metabolic sideeffects: insights from receptor - binding profiles [ J ]. Mol Psychiatry, 2008, 13 ( 1 ) : 27 - 35.
  • 6中华医学会精神科分会.中国精神障碍分类与诊断标准[M].济南:山东科学技术出版社,2001.75-90.
  • 7Henderson DC, Cagliero E, Gray C, et al. Clozapine, diabetes meUi.- ms,weight gain,and lipid abnormalities:A five- year naturalistic study[J]. Am J Psychiatry,2000,157(6) :975 -981.
  • 8曾涛,焦志安,唐济生,高春霓,马中亮.精神分裂症患者的性激素分泌变异[J].中华精神科杂志,1997,30(4):213-216. 被引量:30
  • 9刘朝军,田素英,宋光云,李宝花.齐拉西酮对精神分裂症患者体质量、血糖和泌乳素的影响[J].神经疾病与精神卫生,2009(1):50-52. 被引量:14
  • 10徐勇,于建华.抗精神病药物与精神分裂症病人糖代谢异常[J].齐鲁医学杂志,2010,25(5):469-470. 被引量:14

共引文献54

同被引文献106

  • 1温盛霖,程敏锋,王厚亮,岳计辉,王宏,钟志勇,郑俩荣.精神分裂症患者血清白蛋白、尿酸、胆红素和谷酰转肽酶水平的研究[J].中华临床医师杂志(电子版),2012,6(19):5922-5925. 被引量:23
  • 2沈渔邨.精神病学[M].第5版.北京:人民卫生出版社,2009:215.
  • 3沈渔郦.精神病学[M].第5版.北京:人民卫生出版社,2009:449-450.
  • 4WHO. The world health report 2001 - mental health: new under- standing, new hope [ J]. World Health Organization. 2001,33 -34.
  • 5Bong - Jo Kim, Jin - Wook Sohn, Chul - Soo Park, et al. Body Weight and Plasma Levels of Ghrelin and Leptin during Treatment with Olanzapine[J]. J Korean Med Sci,2008,23(4) : 685 -690.
  • 6Haya Ascher - Svanum, Michael Stensland, Zhongyun Zhao, et al. Acute weight gain, gender, and therapeutic response to antipsychot- ics in the treatment of patients with schizophrenia[ J]. BMC Psychi- atry,2005,5 : 3.
  • 7Hua Jin, Jonathan M. Meyer, et al. Impact of Atypical Antipsyehot- ie Therapy on Leptin, Ghrelin, and Adiponeetin [ J ]. Sehizophr Res. 2008 March; 100(1 -3) : 70 -85.
  • 8钟宇龙,陈文岚,崔文艳,等.3663例住院慢性精神病人尿酸调查分析[J].中外健康文摘,2012,9(27):97-98.
  • 9江沛,蔡弊琳,李焕德,等.代谢组学在神经精神性疾病中的研究进展[J].中国临床药理学,杂志,2011,34(8): 451-454.
  • 10Gutirrez FM, Gandara MJJ, Babes GJ. Switching to ziprasidone in the clinical practice setting: An open-label study [ J ]. Int J Psychiatry Med ,2013,45 (2) : 125-142.

引证文献13

二级引证文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部